Logo image
Commentary: rapamycin for the aging skin
Journal article   Open access   Peer reviewed

Commentary: rapamycin for the aging skin

Christian Sell
GeroScience, v 42(2), pp 813-815
Apr 2020
PMID: 32227278
url
https://doi.org/10.1007/s11357-020-00184-2View
Published, Version of Record (VoR)Open Access (License Unspecified) Open

Abstract

Aging Humans Immunosuppressive Agents Prospective Studies Sirolimus Skin Aging
A response is provided to a commentary on a recent study examining the impact of low-dose topical application of rapamycin on markers of aging in the skin. The barriers to clinical implementation of therapies targeting the fundamental aging process are discussed, and the topical study is placed in context with the broader effort to develop new therapeutics for age-related disorders.

Metrics

2 Record Views
2 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Geriatrics & Gerontology
Logo image